SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'P32'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GRM_A_DVAA8_0
(GRAMICIDIN A)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 GLY B 105
VAL B 102
TRP B 109
TRP B 117
 None
None
None
P32  B 400 (-4.8A)
 1.18A 1grmA-5f8uB:
undetectable		 1grmA-5f8uB:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GRM_B_DVAB8_0
(GRAMICIDIN A)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 GLY B 105
VAL B 102
TRP B 109
TRP B 117
 None
None
None
P32  B 400 (-4.8A)
 1.18A 1grmB-5f8uB:
undetectable		 1grmB-5f8uB:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JO4_A_DVAA8_0
(GRAMICIDIN C)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 GLY B 105
VAL B 102
TRP B 109
TRP B 117
 None
None
None
P32  B 400 (-4.8A)
 1.28A 1jo4A-5f8uB:
undetectable		 1jo4A-5f8uB:
5.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JO4_B_DVAB8_0
(GRAMICIDIN C)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 GLY B 105
VAL B 102
TRP B 109
TRP B 117
 None
None
None
P32  B 400 (-4.8A)
 1.28A 1jo4B-5f8uB:
undetectable		 1jo4B-5f8uB:
5.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y00_A_Y00A601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 LEU B 101
VAL B 102
TRP B 117
ASP B 121
VAL B 122
SER B 211
SER B 215
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 None
None
P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.65A 2y00A-5f8uB:
40.0		 2y00A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y00_A_Y00A601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 LEU B 101
VAL B 125
PHE B 306
ASN B 310
ASN B 329
 None
P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
 1.43A 2y00A-5f8uB:
40.0		 2y00A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y00_A_Y00A601_2
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 VAL B 125
PHE B 201
VAL B 326
TRP B 330
 P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
None
None
 0.65A 2y00A-5f8uB:
40.0		 2y00A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y00_B_Y00B601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 LEU B 101
VAL B 102
TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
PHE B 306
PHE B 307
ASN B 310
TYR B 333
 None
None
P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-4.6A)
 0.62A 2y00B-5f8uB:
39.8		 2y00B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y00_B_Y00B601_2
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		3 / 3 VAL B 122
ASN B 329
TRP B 330
 P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
None
 1.07A 2y00B-5f8uB:
39.8		 2y00B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y00_B_Y00B601_2
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		3 / 3 VAL B 125
ASN B 329
TRP B 330
 P32  B 400 ( 4.7A)
P32  B 400 (-2.9A)
None
 0.53A 2y00B-5f8uB:
39.8		 2y00B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y01_A_Y00A601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 TRP B 117
ASP B 121
PHE B 201
SER B 211
PHE B 306
PHE B 307
ASN B 310
VAL B 326
ASN B 329
TRP B 330
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
None
P32  B 400 (-2.9A)
None
P32  B 400 (-4.6A)
 0.55A 2y01A-5f8uB:
39.6		 2y01A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y01_A_Y00A601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 VAL B 102
TRP B 117
ASP B 121
PHE B 201
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TRP B 330
TYR B 333
 None
P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
None
P32  B 400 (-4.6A)
 0.61A 2y01A-5f8uB:
39.6		 2y01A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y01_B_Y00B601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 LEU B 101
VAL B 102
TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
PHE B 306
PHE B 307
ASN B 310
TYR B 333
 None
None
P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-4.6A)
 0.62A 2y01B-5f8uB:
39.6		 2y01B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y01_B_Y00B601_2
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 VAL B 122
VAL B 326
ASN B 329
TRP B 330
 P32  B 400 (-3.5A)
None
P32  B 400 (-2.9A)
None
 1.16A 2y01B-5f8uB:
39.6		 2y01B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y01_B_Y00B601_2
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 VAL B 125
VAL B 326
ASN B 329
TRP B 330
 P32  B 400 ( 4.7A)
None
P32  B 400 (-2.9A)
None
 0.44A 2y01B-5f8uB:
39.6		 2y01B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y03_A_5FWA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		9 / 12 TRP B 117
ASP B 121
VAL B 122
PHE B 201
SER B 211
SER B 215
PHE B 306
ASN B 310
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-4.6A)
 0.71A 2y03A-5f8uB:
39.7		 2y03A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y03_A_5FWA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 TRP B 117
ASP B 121
VAL B 122
SER B 211
PHE B 306
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.41A 2y03A-5f8uB:
39.7		 2y03A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y03_A_5FWA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 TRP B 117
ASP B 121
VAL B 122
VAL B 125
PHE B 201
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.52A 2y03A-5f8uB:
39.7		 2y03A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y03_B_5FWB601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
PHE B 306
ASN B 329
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-2.9A)
 1.38A 2y03B-5f8uB:
39.7		 2y03B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y03_B_5FWB601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
PHE B 306
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.67A 2y03B-5f8uB:
39.7		 2y03B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y03_B_5FWB601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
VAL B 125
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.44A 2y03B-5f8uB:
39.7		 2y03B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_A_68HA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 11 TRP B 117
ASP B 121
VAL B 122
PHE B 201
SER B 211
SER B 215
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.64A 2y04A-5f8uB:
39.4		 2y04A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_A_68HA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 11 TRP B 117
ASP B 121
VAL B 122
SER B 211
PHE B 306
PHE B 307
ASN B 329
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
 1.38A 2y04A-5f8uB:
39.4		 2y04A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_A_68HA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 11 TRP B 117
ASP B 121
VAL B 122
SER B 215
PHE B 306
PHE B 307
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 1.35A 2y04A-5f8uB:
39.4		 2y04A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_A_68HA601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 11 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.23A 2y04A-5f8uB:
39.4		 2y04A-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_B_68HB601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
ASP B 121
VAL B 122
SER B 215
PHE B 306
PHE B 307
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.29A 2y04B-5f8uB:
39.7		 2y04B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_B_68HB601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
PHE B 307
ASN B 329
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
 1.40A 2y04B-5f8uB:
39.7		 2y04B-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Y04_B_68HB601_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
VAL B 125
PHE B 201
SER B 211
SER B 215
PHE B 306
PHE B 307
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.55A 2y04B-5f8uB:
39.7		 2y04B-5f8uB:
99.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZSE_A_PAUA600_0
(PANTOTHENATE KINASE)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 7 ARG B 317
PHE B 315
ILE B 311
ASN B 310
 None
None
None
P32  B 400 (-3.5A)
 0.94A 2zseA-5f8uB:
undetectable		 2zseA-5f8uB:
21.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D4S_A_TIMA401_1
(BETA-2 ADRENERGIC
RECEPTOR/T4-LYSOZYME
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 215
PHE B 307
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.25A 3d4sA-5f8uB:
39.7		 3d4sA-5f8uB:
41.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D4S_A_TIMA401_1
(BETA-2 ADRENERGIC
RECEPTOR/T4-LYSOZYME
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
VAL B 125
SER B 211
TRP B 303
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-2.7A)
None
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.56A 3d4sA-5f8uB:
39.7		 3d4sA-5f8uB:
41.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D4S_A_TIMA401_2
(BETA-2 ADRENERGIC
RECEPTOR/T4-LYSOZYME
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		3 / 3 THR B 126
SER B 215
PHE B 306
 None
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
 0.36A 3d4sA-5f8uB:
39.7		 3d4sA-5f8uB:
41.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NYA_A_JTZA1203_1
(BETA-2 ADRENERGIC
RECEPTOR, LYSOZYME)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
ASP B 121
VAL B 122
SER B 215
PHE B 306
PHE B 307
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.28A 3nyaA-5f8uB:
39.4		 3nyaA-5f8uB:
41.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NYA_A_JTZA1203_1
(BETA-2 ADRENERGIC
RECEPTOR, LYSOZYME)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
PHE B 307
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.21A 3nyaA-5f8uB:
39.4		 3nyaA-5f8uB:
41.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NYA_A_JTZA1203_1
(BETA-2 ADRENERGIC
RECEPTOR, LYSOZYME)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
VAL B 125
SER B 211
SER B 215
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.53A 3nyaA-5f8uB:
39.4		 3nyaA-5f8uB:
41.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RZE_A_D7VA1201_1
(HISTAMINE H1
RECEPTOR, LYSOZYME
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 ASP B 121
THR B 126
ILE B 129
TRP B 303
PHE B 307
TYR B 333
 P32  B 400 (-2.2A)
None
None
None
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 0.70A 3rzeA-5f8uB:
31.1		 3rzeA-5f8uB:
26.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AMJ_A_CVDA1359_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
ASP B 121
VAL B 122
SER B 215
PHE B 306
PHE B 307
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.24A 4amjA-5f8uB:
12.0		 4amjA-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AMJ_A_CVDA1359_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 TRP B 117
ASP B 121
VAL B 122
VAL B 125
SER B 211
SER B 215
TRP B 303
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.60A 4amjA-5f8uB:
12.0		 4amjA-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AMJ_B_CVDB1360_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 LEU B 101
TRP B 117
ASP B 121
SER B 215
PHE B 306
PHE B 307
ASN B 329
TYR B 333
 None
P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.09A 4amjB-5f8uB:
40.2		 4amjB-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AMJ_B_CVDB1360_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		12 / 12 LEU B 101
TRP B 117
ASP B 121
VAL B 125
SER B 211
SER B 215
TRP B 303
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 None
P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 ( 4.7A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.61A 4amjB-5f8uB:
40.2		 4amjB-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AMJ_B_CVDB1360_2
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 4 VAL B 122
ASP B 200
TYR B 207
TRP B 330
 P32  B 400 (-3.5A)
None
None
None
 0.58A 4amjB-5f8uB:
40.2		 4amjB-5f8uB:
99.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4IAQ_A_2GMA2001_1
(CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 1B AND E.
COLI SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 ASP B 121
TRP B 303
PHE B 306
PHE B 307
PHE B 325
 P32  B 400 (-2.2A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
None
 0.82A 4iaqA-5f8uB:
31.9		 4iaqA-5f8uB:
31.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4IAR_A_ERMA2001_2
(CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 1B AND E.
COLI SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 7 TRP B 117
THR B 126
SER B 211
PHE B 307
 P32  B 400 (-4.8A)
None
P32  B 400 (-2.7A)
P32  B 400 (-4.9A)
 0.58A 4iarA-5f8uB:
30.5		 4iarA-5f8uB:
31.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IB4_A_ERMA2001_1
(CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 2B AND E.
COLI SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 122
TRP B 303
PHE B 306
PHE B 307
VAL B 314
 P32  B 400 (-3.5A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
None
 0.60A 4ib4A-5f8uB:
28.1		 4ib4A-5f8uB:
29.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IB4_A_ERMA2001_1
(CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 2B AND E.
COLI SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 122
VAL B 202
TRP B 303
PHE B 306
PHE B 307
 P32  B 400 (-3.5A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
 1.06A 4ib4A-5f8uB:
28.1		 4ib4A-5f8uB:
29.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LDO_A_ALEA1402_1
(LYSOZYME, BETA-2
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 10 ASP B 121
VAL B 122
SER B 211
PHE B 306
ASN B 329
 P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-2.9A)
 1.44A 4ldoA-5f8uB:
34.3		 4ldoA-5f8uB:
42.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LDO_A_ALEA1402_1
(LYSOZYME, BETA-2
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 10 ASP B 121
VAL B 122
VAL B 125
PHE B 201
SER B 211
SER B 215
PHE B 306
ASN B 310
 P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 1.01A 4ldoA-5f8uB:
34.3		 4ldoA-5f8uB:
42.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LDO_A_ALEA1402_1
(LYSOZYME, BETA-2
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 10 ASP B 121
VAL B 122
VAL B 125
SER B 211
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.76A 4ldoA-5f8uB:
34.3		 4ldoA-5f8uB:
42.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LDO_A_ALEA1402_1
(LYSOZYME, BETA-2
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 10 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.49A 4ldoA-5f8uB:
34.3		 4ldoA-5f8uB:
42.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TUD_D_ERMD1201_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2B,SOLUBLE
CYTOCHROME B562
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 ASP B 121
PHE B 306
PHE B 307
ASN B 310
VAL B 314
 P32  B 400 (-2.2A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
None
 0.75A 5tudD-5f8uB:
28.6		 5tudD-5f8uB:
29.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A93_A_8NUA3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 126
ILE B 129
PHE B 299
TRP B 303
PHE B 306
PHE B 307
TYR B 333
 P32  B 400 (-4.8A)
None
None
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 0.69A 6a93A-5f8uB:
29.1		 6a93A-5f8uB:
31.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A93_B_8NUB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 TRP B 117
VAL B 122
THR B 126
TRP B 303
PHE B 306
PHE B 307
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
 0.63A 6a93B-5f8uB:
31.1		 6a93B-5f8uB:
31.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A93_B_8NUB3001_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 5 ASP B 121
ILE B 129
PHE B 299
TYR B 333
 P32  B 400 (-2.2A)
None
None
P32  B 400 (-4.6A)
 0.55A 6a93B-5f8uB:
31.1		 6a93B-5f8uB:
31.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A94_A_ZOTA3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 TRP B 117
PHE B 299
TRP B 303
PHE B 306
PHE B 307
ASN B 310
 P32  B 400 (-4.8A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 0.75A 6a94A-5f8uB:
31.2		 6a94A-5f8uB:
31.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A94_A_ZOTA3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 TRP B 117
SER B 215
PHE B 299
TRP B 303
PHE B 306
PHE B 307
 P32  B 400 (-4.8A)
P32  B 400 ( 4.2A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
 0.66A 6a94A-5f8uB:
31.2		 6a94A-5f8uB:
31.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A94_B_ZOTB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 VAL B 122
THR B 126
SER B 215
PHE B 299
TRP B 303
PHE B 306
PHE B 307
 P32  B 400 (-3.5A)
None
P32  B 400 ( 4.2A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
 0.66A 6a94B-5f8uB:
31.4		 6a94B-5f8uB:
31.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CM4_A_8NUA2001_0
(D(2) DOPAMINE
RECEPTOR, ENDOLYSIN
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 VAL B 122
THR B 126
PHE B 299
TRP B 303
PHE B 307
TYR B 333
 P32  B 400 (-3.5A)
None
None
None
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 0.73A 6cm4A-5f8uB:
30.3		 6cm4A-5f8uB:
30.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DRX_A_H8GA1201_0
(5HT2B RECEPTOR, BRIL
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 TRP B 117
VAL B 122
THR B 126
PHE B 306
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
None
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.67A 6drxA-5f8uB:
29.6		 6drxA-5f8uB:
29.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DRX_A_H8GA1201_0
(5HT2B RECEPTOR, BRIL
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 122
THR B 126
TRP B 303
PHE B 306
ASN B 310
 P32  B 400 (-3.5A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.87A 6drxA-5f8uB:
29.6		 6drxA-5f8uB:
29.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DRX_A_H8GA1201_0
(5HT2B RECEPTOR, BRIL
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 122
TRP B 303
PHE B 306
ASN B 310
TYR B 333
 P32  B 400 (-3.5A)
None
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-4.6A)
 0.61A 6drxA-5f8uB:
29.6		 6drxA-5f8uB:
29.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DRY_A_H8DA2001_0
(5HT2B RECEPTOR, BRIL
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 11 ASP B 121
VAL B 122
THR B 126
PHE B 306
TYR B 333
 P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.6A)
 0.81A 6dryA-5f8uB:
26.9		 6dryA-5f8uB:
30.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DRZ_A_H8JA1206_0
(5HT2B RECEPTOR, BRIL
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 VAL B 122
THR B 126
PHE B 306
PHE B 307
ASN B 310
TYR B 333
 P32  B 400 (-3.5A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-4.6A)
 0.71A 6drzA-5f8uB:
29.4		 6drzA-5f8uB:
30.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DRZ_A_H8JA1206_0
(5HT2B RECEPTOR, BRIL
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 VAL B 122
THR B 126
VAL B 202
PHE B 306
PHE B 307
ASN B 310
 P32  B 400 (-3.5A)
None
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 1.03A 6drzA-5f8uB:
29.4		 6drzA-5f8uB:
30.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_A_5FWA401_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		10 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.61A 6h7jA-5f8uB:
34.0		 6h7jA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_A_5FWA401_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 212
PHE B 307
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
None
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 0.70A 6h7jA-5f8uB:
34.0		 6h7jA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_A_5FWA401_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 212
SER B 215
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
None
P32  B 400 ( 4.2A)
P32  B 400 (-3.5A)
 0.77A 6h7jA-5f8uB:
34.0		 6h7jA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_A_5FWA401_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
PHE B 306
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.73A 6h7jA-5f8uB:
34.0		 6h7jA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_A_5FWA401_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 215
PHE B 307
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 1.35A 6h7jA-5f8uB:
34.0		 6h7jA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_A_5FWA401_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.37A 6h7jA-5f8uB:
34.0		 6h7jA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_B_5FWB402_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		10 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.60A 6h7jB-5f8uB:
34.7		 6h7jB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_B_5FWB402_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 212
PHE B 307
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
None
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 0.69A 6h7jB-5f8uB:
34.7		 6h7jB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_B_5FWB402_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 212
SER B 215
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
None
P32  B 400 ( 4.2A)
P32  B 400 (-3.5A)
 0.78A 6h7jB-5f8uB:
34.7		 6h7jB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_B_5FWB402_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
PHE B 306
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.73A 6h7jB-5f8uB:
34.7		 6h7jB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_B_5FWB402_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 215
PHE B 307
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 1.34A 6h7jB-5f8uB:
34.7		 6h7jB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7J_B_5FWB402_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.37A 6h7jB-5f8uB:
34.7		 6h7jB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_A_Y00A406_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 VAL B 102
TRP B 117
ASP B 121
VAL B 122
SER B 215
TRP B 330
TYR B 333
 None
P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
None
P32  B 400 (-4.6A)
 1.34A 6h7lA-5f8uB:
34.1		 6h7lA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_A_Y00A406_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 VAL B 102
TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
ASN B 310
VAL B 326
ASN B 329
TRP B 330
TYR B 333
 None
P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-3.5A)
None
P32  B 400 (-2.9A)
None
P32  B 400 (-4.6A)
 0.80A 6h7lA-5f8uB:
34.1		 6h7lA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_A_Y00A406_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		9 / 12 VAL B 102
TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
ASN B 310
TRP B 330
 None
P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-3.5A)
None
 0.89A 6h7lA-5f8uB:
34.1		 6h7lA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_A_Y00A406_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 6 GLY B  98
LEU B 101
PHE B 201
PHE B 307
 None
None
P32  B 400 (-4.0A)
P32  B 400 (-4.9A)
 0.75A 6h7lA-5f8uB:
34.1		 6h7lA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_A_Y00A406_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 6 GLY B  98
LEU B 101
VAL B 125
PHE B 306
PHE B 307
 None
None
P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
 0.38A 6h7lA-5f8uB:
34.1		 6h7lA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 TRP B 117
ASP B 121
VAL B 122
SER B 215
TRP B 330
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
None
P32  B 400 (-4.6A)
 1.23A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		10 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
ASN B 310
VAL B 326
ASN B 329
TRP B 330
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-3.5A)
None
P32  B 400 (-2.9A)
None
P32  B 400 (-4.6A)
 0.76A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 VAL B 102
TRP B 117
ASP B 121
VAL B 122
SER B 215
TRP B 330
 None
P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
None
 1.33A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		10 / 12 VAL B 102
TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
ASN B 310
VAL B 326
ASN B 329
TRP B 330
 None
P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 (-3.5A)
None
P32  B 400 (-2.9A)
None
 0.77A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		9 / 12 VAL B 102
TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 211
SER B 215
ASN B 310
TRP B 330
 None
P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-3.5A)
None
 0.88A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		4 / 6 GLY B  98
LEU B 101
PHE B 201
PHE B 307
 None
None
P32  B 400 (-4.0A)
P32  B 400 (-4.9A)
 0.77A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7L_B_Y00B405_1
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 6 GLY B  98
LEU B 101
VAL B 125
PHE B 306
PHE B 307
 None
None
P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
 0.38A 6h7lB-5f8uB:
34.5		 6h7lB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_A_68HA504_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 THR B 118
ASP B 121
VAL B 122
PHE B 201
PHE B 307
ASN B 310
 P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-4.0A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 1.46A 6h7mA-5f8uB:
34.3		 6h7mA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_A_68HA504_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
PHE B 201
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.55A 6h7mA-5f8uB:
34.3		 6h7mA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_A_68HA504_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		9 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
PHE B 201
SER B 211
SER B 215
PHE B 306
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.68A 6h7mA-5f8uB:
34.3		 6h7mA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_A_68HA504_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		7 / 12 TRP B 117
THR B 118
ASP B 121
VAL B 122
SER B 215
PHE B 307
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 1.35A 6h7mA-5f8uB:
34.3		 6h7mA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_A_68HA504_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.32A 6h7mA-5f8uB:
34.3		 6h7mA-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_B_68HB405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		6 / 12 TRP B 117
ASP B 121
VAL B 122
SER B 215
PHE B 307
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.9A)
P32  B 400 (-4.6A)
 1.37A 6h7mB-5f8uB:
34.6		 6h7mB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_B_68HB405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		11 / 12 TRP B 117
ASP B 121
VAL B 122
VAL B 125
PHE B 201
SER B 211
PHE B 306
PHE B 307
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.58A 6h7mB-5f8uB:
34.6		 6h7mB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_B_68HB405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		9 / 12 TRP B 117
ASP B 121
VAL B 122
VAL B 125
PHE B 201
SER B 211
SER B 215
PHE B 306
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-2.2A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-2.7A)
P32  B 400 ( 4.2A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
 0.71A 6h7mB-5f8uB:
34.6		 6h7mB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6H7M_B_68HB405_0
(BETA-1 ADRENERGIC
RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.32A 6h7mB-5f8uB:
34.6		 6h7mB-5f8uB:
86.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6IBL_A_H98A501_0
(THIOREDOXIN 1,BETA-1
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
VAL B 122
VAL B 125
PHE B 201
TRP B 303
PHE B 307
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
None
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 0.88A 6iblA-5f8uB:
34.2		 6iblA-5f8uB:
73.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6IBL_A_H98A501_0
(THIOREDOXIN 1,BETA-1
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		10 / 12 TRP B 117
THR B 118
VAL B 122
VAL B 125
TRP B 303
PHE B 306
PHE B 307
ASN B 310
VAL B 326
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
None
P32  B 400 (-4.6A)
 0.66A 6iblA-5f8uB:
34.2		 6iblA-5f8uB:
73.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6IBL_A_H98A501_0
(THIOREDOXIN 1,BETA-1
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 122
PHE B 306
PHE B 307
ASN B 310
VAL B 326
 P32  B 400 (-3.5A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
None
 1.33A 6iblA-5f8uB:
34.2		 6iblA-5f8uB:
73.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6IBL_B_H98B501_0
(THIOREDOXIN 1,BETA-1
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
THR B 118
VAL B 122
VAL B 125
PHE B 201
TRP B 303
PHE B 307
ASN B 310
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
None
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
 0.89A 6iblB-5f8uB:
34.3		 6iblB-5f8uB:
73.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6IBL_B_H98B501_0
(THIOREDOXIN 1,BETA-1
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		10 / 12 TRP B 117
THR B 118
VAL B 122
VAL B 125
TRP B 303
PHE B 306
PHE B 307
ASN B 310
VAL B 326
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
None
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
None
P32  B 400 (-4.6A)
 0.67A 6iblB-5f8uB:
34.3		 6iblB-5f8uB:
73.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6IBL_B_H98B501_0
(THIOREDOXIN 1,BETA-1
ADRENERGIC RECEPTOR)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 122
PHE B 306
PHE B 307
ASN B 310
VAL B 326
 P32  B 400 (-3.5A)
P32  B 400 (-4.1A)
P32  B 400 (-4.9A)
P32  B 400 (-3.5A)
None
 1.38A 6iblB-5f8uB:
34.3		 6iblB-5f8uB:
73.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MXT_A_K5YA1401_0
(ENDOLYSIN, BETA-2
ADRENERGIC RECEPTOR
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 TRP B 117
VAL B 122
ASP B 200
PHE B 201
PHE B 307
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
None
P32  B 400 (-4.0A)
P32  B 400 (-4.9A)
 1.35A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MXT_A_K5YA1401_0
(ENDOLYSIN, BETA-2
ADRENERGIC RECEPTOR
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 TRP B 117
VAL B 122
VAL B 125
ASP B 200
PHE B 201
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
None
P32  B 400 (-4.0A)
 0.90A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MXT_A_K5YA1401_0
(ENDOLYSIN, BETA-2
ADRENERGIC RECEPTOR
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		8 / 12 TRP B 117
VAL B 122
VAL B 125
PHE B 201
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 (-4.8A)
P32  B 400 (-3.5A)
P32  B 400 ( 4.7A)
P32  B 400 (-4.0A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 0.75A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MXT_A_K5YA1401_0
(ENDOLYSIN, BETA-2
ADRENERGIC RECEPTOR
CHIMERA)		 5f8u BETA-1 ADRENERGIC
RECEPTOR
(Meleagris
gallopavo) 		5 / 12 VAL B 125
PHE B 306
ASN B 310
ASN B 329
TYR B 333
 P32  B 400 ( 4.7A)
P32  B 400 (-4.1A)
P32  B 400 (-3.5A)
P32  B 400 (-2.9A)
P32  B 400 (-4.6A)
 1.46A 6mxtA-5f8uB:
35.0		 6mxtA-5f8uB:
41.56